Hyperglycemia leads to poorer clinical outcomes, with increased morbidity and mortality in both critically ill and non-critically ill people. Improving blood glucose levels reduces length of hospital stay, systemic infections and short- and long-term mortality. Egyptian physicians evaluated the efficacy of insulin degludec compared to insulin glargine and regular insulin in controlling blood glucose levels.
You May Also Like
- Rare pulmonary syndromes
Yellow nail and Swyer-James syndrome
- Vaccinations against viral respiratory infections
Influenza, Covid-19 and RSV – Update 2025
- GLP1-RA therapy
Improvement in either weight or HbA1c – but never both
- Suicide
Dealing with trauma after suicide loss: What do bereaved people experience as effective?
- COPD exacerbations
Fast therapy initiation is not much better than expected
- Collagenoses
Scleroderma – Current recommendations for diagnosis and therapy 2025
- Galenic systems
Advantages of topical pharmacotherapy – Update 2025
- Psychedelics and related drug classes